ASCO RECENTLY launched its new “I Live to Conquer Cancer” national outreach and awareness campaign to draw attention to the critical importance of federally funded cancer research.
Through a series of compelling videos and written stories, “I Live to Conquer Cancer” puts a human face on cancer research and spotlights federally funded cancer researchers who have devoted their lives to clinical cancer research, as well as the patients who inspire them to continue progress against cancer.
Watch and share these videos, which feature Raymond U. Osarogiagbon, MD, FACP, of Baptist Cancer Center; Tara O. Henderson, MD, MPH, of University of Chicago Medicine; and Judith S. Kaur, MD, of Mayo Clinic Cancer Center. Additional videos will be available later this summer and throughout the year.
These stories represent just a fraction of the experiences of cancer researchers. As part of the campaign, ASCO invites all cancer researchers who have received federal funding to share why they live to conquer cancer. Stories can be shared in several ways:
- Answer the question “Why do I live to conquer cancer?” on Twitter using the hashtag #LiveToConquerCancer.
- Film a short video and send it directly to ASCO. Many of the videos ASCO receives will be posted on ASCO.org.
- Write a short blog post about why you live to conquer cancer and send it to ASCO.
ASCO has created a series of resources to help spread the message of the campaign. Materials include a social media toolkit, infographic on the cancer research pipeline, a brochure on the importance of federal funding, and a timeline of important cancer advances that were made possible through federally funded research. These resources and everything needed to join the “I Live to Conquer Cancer” campaign can be found at asco.org/live-to-conquer-cancer.
A chorus of voices will send a strong message to policymakers that now is the time to invest more— not less—in cancer research.
Find the latest updates on the campaign at asco.org/live-to-conquer-cancer. ■
© 2018. American Society of Clinical Oncology. All rights reserved.
